VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) dropped 14.7% on Wednesday . The company traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares were traded during mid-day trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Trading Down 9.1 %
The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The business’s 50-day moving average price is C$0.11 and its two-hundred day moving average price is C$0.13. The company has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Airline Stocks – Top Airline Stocks to Buy Now
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
